Skip to main content

Eugeni Bruguera Cortada

Institutions of which they are part

Senior researcher
Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca

Eugeni Bruguera Cortada

Institutions of which they are part

Senior researcher
Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca

Projects

An effectiveness and safety study of varenicline for smoking cessation in hospitalized patients with psychiatric disorders

IP: Eugeni Bruguera Cortada
Collaborators: -
Funding agency: Pfizer Inc
Funding: 90196.52
Reference: VARENICLINE_WI231379-PFIZER2017
Duration: 29/01/2018 - 01/04/2020

Related news

The European project DISCOvERIE, led by Vall d’Hebron, paves the way for more personalized diagnoses and new treatment strategies to improve patients’ quality of life.

The meeting takes place within the framework of Healing Arts Barcelona, with the aim of exploring and debating how participation in artistic activities can help improve physical and mental health.

Genetic susceptibility to developing ADHD shows the strongest association with mental health problems during childhood and adolescence, compared to genetic risk for other psychiatric conditions.

Related professionals

Blanca  Borras  Bermejo

Blanca Borras Bermejo

Predoctoral researcher
Epidemiology and Public Health
Read more
Mònica Faro Colomés

Mònica Faro Colomés

Junior researcher
Systemic Diseases
Read more
Antonio González Fernández

Antonio González Fernández

Senior researcher
Systemic Diseases
Read more
Lluis Castells Fusté

Lluis Castells Fusté

Liver Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.